NIVAS News Hub

Do you have news you would like to share on the NIVAS News Hub?

If you have an RSS feed you wish to share with up please contact us here.

Showing 169-180 of 1133 results.

IVTEAM

Intranasal fentanyl in preterm infants undergoing PICC placement – Full Text

"The objectives of this blinded randomized controlled trial (RCT) were to assess the feasibility of conducting a definitive RCT of IN fentanyl for PICC placement in preterm infants and evaluate the acceptability and adoption of IN fentanyl for procedural pain management in the NICU" Tabbara et al (2025).

IVTEAM

Subcutaneous biologic drug development – Full Text

"In conclusion, making minimal drug formulation concentration changes to an IV biologic formulation may reduce the risk, time commitment, and cost associated with developing a SC biologic formulation. Further education is needed around the transition of traditional IV formulations to low-concentration, large-volume SC formulations utilizing delivery formats such as an SC infusion pump or OBDS" Desai et al (2025).

IVTEAM

Antineoplastic extravasation management guideline

"This guideline summarizes evidence-based interventions for the management of extravasation of antineoplastic vesicants or irritants with vesicant properties to guide clinical care" Thomas et al (2025).

IVTEAM

Vascular access device selection survey

"The study underscores the need for standardised practices, interdisciplinary collaboration, and enhanced training. Findings highlight opportunities for integrating VAD selection into cancer care certification metrics and fostering partnerships between oncology and vascular access societies" Duggan et al (2025).

IVTEAM

Extravasation detection in neonates

"To examine the evidence on SPC infiltration and extravasation complications in neonates, focusing on incidence, risk factors, detection tools, research gaps, and opportunities for standardization" van Rens et al (2025).

IVTEAM

Impact of IV drug shortages on patient safety

"Almost half (44%) of the survey respondents reported shortages impacting hematology and oncology medications. These shortages resulted in interrupted, modified, or delayed chemotherapy regimens (e.g., reduced doses, treatment withheld if noncurative intent) and significantly impacted health care organizations' clinical and operational resources, increased the risk for medication errors, and negatively affected the quality of patient care" Bertagnoli et al (2025).

NIVAS Partners

The NIVAS Board

UK Vessel Health & Preservation Video